![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Alzheimer's Disease |
|
Free Subscription
1 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
Retinal proteome changes mirror brain pathology and reveal synaptic and
cytoskeletal dysfunction in Alzheimer's disease.
Acta Neuropathol. 2026;152:12.
PubMed
Abstract available
Cross-ancestry polygenic risk scores enhance Alzheimer's disease risk prediction
in multiethnic cohorts.
Alzheimers Dement. 2026;22:e71529.
PubMed
Abstract available
Associations of dementia polyexposure scores to Alzheimer's disease
endophenotypes in a diverse population.
Alzheimers Dement. 2026;22:e71567.
PubMed
Abstract available
Classification of tau status with machine learning models in amyloid-positive
cohorts.
Alzheimers Dement. 2026;22:e71683.
PubMed
Abstract available
Exploring longitudinal relationships among Alzheimer's disease biomarkers.
Alzheimers Dement. 2026;22:e71711.
PubMed
Abstract available
Evaluating digital cognitive tests for clinical use in Alzheimer's disease: A
novel framework and scoping review.
Alzheimers Dement. 2026;22:e71559.
PubMed
Abstract available
Heterogeneity in plasma p-tau217 response and its association with cognitive
trajectories under lecanemab treatment.
Alzheimers Dement. 2026;22:e71705.
PubMed
Abstract available
Refining our understanding of sleep impairment and connection to Alzheimer's
disease in preclinical models.
Alzheimers Dement. 2026;22:e71700.
PubMed
Reproductive neuroendocrine pathways as modulators of sleep-related sex
differences in Alzheimer's disease.
Alzheimers Dement. 2026;22:e71699.
PubMed
Recent Cochrane review has serious flaws: A perspective of clinicians and
researchers from around the world.
Alzheimers Dement. 2026;22:e71696.
PubMed
Abstract available
Analytical framing of Amyloid beta monoclonal antibody trials in Alzheimer's
disease can obscure clinical effects.
Alzheimers Dement. 2026;22:e71646.
PubMed
Abstract available
Alzheimer's blood-based biomarkers, incident dementia, and interactions with age,
APOE status, and hormone therapy.
Alzheimers Dement. 2026;22:e71704.
PubMed
Abstract available
Standardizing care for agitation in Alzheimer's disease, results from a
randomized controlled trial of an integrated care pathway versus usual care - the
StaN trial.
Alzheimers Dement. 2026;22:e71610.
PubMed
Abstract available
The Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale in frontotemporal
dementia and Alzheimer's disease.
Alzheimers Dement. 2026;22:e71686.
PubMed
Abstract available
Neuropathology in a diverse cohort of oldest-old: The LifeAfter90 study.
Alzheimers Dement. 2026;22:e71634.
PubMed
Abstract available
Theoretical and practical challenges for capturing reserve and resilience in
aging and Alzheimer's disease: A narrative review.
Alzheimers Dement. 2026;22:e71664.
PubMed
Abstract available
Sustained fish intake and 21-year Alzheimer's disease risk: a target trial
emulation.
Am J Epidemiol. 2026 Jul 27:kwag140. doi: 10.1093.
PubMed
Abstract available
Brexpiprazole With Antidepressants for Agitation in Alzheimer's Dementia: Post
Hoc Analysis.
Am J Geriatr Psychiatry. 2026 Jun 30:S1064-7481(26)00450.
PubMed
Abstract available
Blood Biomarkers of Alzheimer's Disease and Patterns of Structural Brain Changes
in the Community.
Ann Neurol. 2026 Jul 27. doi: 10.1002/ana.78309.
PubMed
Abstract available
Neuromodulation in Alzheimer's disease: a review with illustrative pilot data
using focused ultrasound.
Biol Psychiatry. 2026 Jul 30:S0006-3223(26)01440.
PubMed
Abstract available
Interpreting early default mode network dysfunction across the Alzheimer's
disease spectrum.
Brain. 2026 Jul 25:awag253. doi: 10.1093.
PubMed
Reply: Interpreting early default mode network dysfunction across the Alzheimer's
disease Spectrum.
Brain. 2026 Jul 25:awag254. doi: 10.1093.
PubMed
Alzheimer disease in the computational era: from a deterministic disease to a
multifaceted disorder.
Brain. 2026 Jul 30:awag248. doi: 10.1093.
PubMed
Abstract available
Integrating Multi-Omics and Mendelian Randomization Reveals the Role of
Epstein-Barr Virus Infection in Alzheimer's Disease and the Therapeutic Potential
of Resveratrol.
Curr Alzheimer Res. 2026 Jul 21. doi: 10.2174/0115672050463115260708111634.
PubMed
Abstract available
Cognitive Profiles in Early- and Late-Onset Alzheimer's Disease: The Role of
Dementia Severity in Typical Amnestic Presentations Using the Addenbrooke's
Cognitive Examination III.
Curr Alzheimer Res. 2026 Jul 21. doi: 10.2174/0115672050489392260702044957.
PubMed
Abstract available
Depression and Risk of Alzheimer's Disease: A Mendelian Randomization Study.
Curr Alzheimer Res. 2026 Jul 22. doi: 10.2174/0115672050477354260714063740.
PubMed
Abstract available
Functional staging of Alzheimer's disease dementia with Addenbrooke Cognitive
Examination-III: evidence for subtype-specific cognitive thresholds.
Dement Geriatr Cogn Disord. 2026 Jul 28:1. doi: 10.1159.
PubMed
Abstract available
Neuropsychiatric symptoms as early clinical indicators and functional biomarkers
of cognitive decline in mild cognitive impairment and early Alzheimer's disease.
J Alzheimers Dis. 2026 Jul 27:13872877261469114. doi: 10.1177/13872877261469114.
PubMed
Abstract available
Integration of multi-omics and artificial intelligence for therapeutic insights
in Alzheimer's disease: A comprehensive review.
J Alzheimers Dis. 2026 Jul 27:13872877261471812. doi: 10.1177/13872877261471812.
PubMed
Abstract available
Global trends in Alzheimer's and dementia research (2019-2024): A machine
learning-based bibliometric analysis.
J Alzheimers Dis. 2026 Jul 28:13872877261471922. doi: 10.1177/13872877261471922.
PubMed
Abstract available
[18F]-florzolotau PET imaging in Alzheimer's disease: Current evidence and future
directions.
J Alzheimers Dis. 2026 Jul 28:13872877261469867. doi: 10.1177/13872877261469867.
PubMed
Abstract available
Retraction: Detection of Peri-Synaptic Amyloid-beta Pyroglutamate Aggregates in
Early Stages of Alzheimer's Disease and in AbetaPP Transgenic Mice Using a Novel
Monoclonal Antibody.
J Alzheimers Dis. 2026 Jul 31:13872877261474572. doi: 10.1177/13872877261474572.
PubMed
Artificial intelligence in retinal imaging for early Alzheimer's disease
detection: A review.
J Alzheimers Dis. 2026 Jul 31:13872877261473304. doi: 10.1177/13872877261473304.
PubMed
Abstract available
Microglial immunometabolic reprogramming in Alzheimer's disease: From
mitochondrial dysfunction and redox imbalance to NLRP3 inflammasome-driven
neuroinflammation.
J Alzheimers Dis. 2026 Jul 31:13872877261469862. doi: 10.1177/13872877261469862.
PubMed
Abstract available
Minor hallucinations as an early marker to differentiate dementia with Lewy
bodies from Alzheimer's disease.
J Alzheimers Dis. 2026 Jul 29:13872877261468798. doi: 10.1177/13872877261468798.
PubMed
Abstract available
Exploring the relationship between Alzheimer's disease and lower extremity
isokinetic muscle strength in community-dwelling older adults: A cross-sectional
observational study.
J Alzheimers Dis. 2026 Jul 29:13872877261471888. doi: 10.1177/13872877261471888.
PubMed
Abstract available
Novel blood lncRNA biomarkers associated with clinical severity and specific
cognitive dimensions in Alzheimer's disease.
J Alzheimers Dis. 2026 Jul 29:13872877261470430. doi: 10.1177/13872877261470430.
PubMed
Abstract available
Mild behavioral impairment-apathy and Alzheimer's disease plasma phosphorylated
tau biomarker levels.
J Alzheimers Dis. 2026 Jul 29:13872877261470257. doi: 10.1177/13872877261470257.
PubMed
Abstract available
"A light, A breath": A community-based temporary care model for enhancing quality
of life in Alzheimer's disease patients and supporting caregivers.
J Alzheimers Dis. 2026 Jul 28:13872877261471873. doi: 10.1177/13872877261471873.
PubMed
Abstract available
Heterogeneity in the association between antihypertensive medications and
Alzheimer's disease and related dementias risk: A multidimensional machine
learning analysis to inform drug repurposing.
J Alzheimers Dis. 2026 Jul 28:13872877261469115. doi: 10.1177/13872877261469115.
PubMed
Abstract available
Agreement between clinical diagnosis and blood biomarkers of Alzheimer's disease
in a real-world peripheral memory clinic.
J Alzheimers Dis. 2026 Jul 28:13872877261469893. doi: 10.1177/13872877261469893.
PubMed
Abstract available
NegotiAge-An AI-Based Caregiver Negotiation Training: Results From the Multiphase
Optimization Strategy (MOST) Trial.
J Am Geriatr Soc. 2026;74:2032-2040.
PubMed
Abstract available
Comments on "Persistent Functional Impairment as an Early Indicator of Alzheimer
Disease Pathology and Progression".
J Am Geriatr Soc. 2026 Jul 30. doi: 10.1111/jgs.70614.
PubMed
Mitochondrial accumulation and lysosomal dysfunction result in mitochondrial
plaques in Alzheimer's disease.
Nat Neurosci. 2026 Jul 29. doi: 10.1038/s41593-026-02390.
PubMed
Abstract available
Association of Sugar Restriction in Utero Through Age 2 Years on Dementia Risk
Later in Life.
Neurology. 2026;107:e218313.
PubMed
Abstract available
Autoimmune Neurologic Disorders and the Risk of Alzheimer, Vascular, and Other
Dementias: A Comprehensive Systematic Review and Meta-Analysis (P2-13.006).
Neurology. 2026;107:e218536.
PubMed
Epileptiform discharges are associated with increased theta activity over time in
patients with Lewy body dementia.
Neuroscience. 2026 Jul 3:S0306-4522(26)00429.
PubMed
Abstract available
Non-transgenic rodent models associated with Alzheimer's disease: applications,
evaluation, and perspectives.
Neuroscience. 2026 Jul 28:S0306-4522(26)00507.
PubMed
Abstract available
Validation of Plasma p-tau217 as a Biomarker of Prodromal Alzheimer's Disease.
Rev Neurol. 2026;81:50619.
PubMed
Abstract available
AI-Enabled Modeling for Alzheimer's Disease Risk Prediction and Validation.
Rev Neurol. 2026;81:49220.
PubMed
Abstract available
Thank you for your interest in scientific medicine.